PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.\', \'Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool, UK.\', \'Department of Infectious Diseases, Christian Medical College, Vellore, India.\', \'Department of Clinical Pharmacology, Royal Liverpool University Hospital, Liverpool, UK.\', \'Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.\', \'Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/14651858.CD013587.pub2
?:hasPublicationType
?:journal
  • The Cochrane database of systematic reviews
is ?:pmid of
?:pmid
?:pmid
  • 33624299
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all